Want to join the conversation?
Mike Weinstein of JPMorgan asked about the performance of respective businesses in 2016 vs. 2015? $JNJ's CFO Dominic Caruso said, the company's growth in 2015 was driven by pharmaceuticals and it expects a healthy growth in 2016 from pharma, but lesser than 2015 rate. Conversely $JNJ is expecting better growth in consumer and medical device.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)